Nycomed is about to establish its own marketing and sales organisation in Venezuela. With this, the company will operate from an own subsidiary in all four leading Latin American pharmaceutical markets, Mexico, Brazil, Venezuela and Argentina. This is part of Nycomed's strategy to strengthen its presence in high-growth markets and offer licensing opportunities to partners.
Venezuela is the third largest pharmaceutical market in Latin America, with a total value of US-$ 3 billion and annual growth of 29 percent. Nycomed's products Pantoprazole for the treatment of acid-related gastrointestinal disorders and Ciclesonide for the treatment of asthma are successfully promoted in the South American country by partners.
Discuss Add this link to... Bury
Venezuela is the third largest pharmaceutical market in Latin America, with a total value of US-$ 3 billion and annual growth of 29 percent. Nycomed's products Pantoprazole for the treatment of acid-related gastrointestinal disorders and Ciclesonide for the treatment of asthma are successfully promoted in the South American country by partners.
Discuss Add this link to... Bury
Comments